ABVC BioPharma Inc (ABVC)
1.03
+0.01
(+0.98%)
USD |
NASDAQ |
Apr 18, 16:00
1.05
+0.02
(+1.94%)
After-Hours: 06:04
ABVC BioPharma Cash from Operations (TTM): -4.236M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.236M |
| September 30, 2023 | -4.218M |
| June 30, 2023 | -3.372M |
| March 31, 2023 | -5.902M |
| December 31, 2022 | -7.398M |
| September 30, 2022 | -9.462M |
| June 30, 2022 | -11.16M |
| March 31, 2022 | -9.179M |
| December 31, 2021 | -7.598M |
| September 30, 2021 | -7.261M |
| June 30, 2021 | -5.374M |
| March 31, 2021 | -5.346M |
| December 31, 2020 | -4.564M |
| September 30, 2020 | -3.872M |
| June 30, 2020 | -3.785M |
| March 31, 2020 | -3.166M |
| December 31, 2019 | -3.134M |
| September 30, 2019 | -1.101M |
| June 30, 2019 | -1.069M |
| March 31, 2019 | -0.7042M |
| December 31, 2018 | -0.6302M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | -1.599M |
| June 30, 2017 | -1.487M |
| March 31, 2017 | -4.133M |
| December 31, 2016 | -2.825M |
| September 30, 2016 | -3.475M |
| June 30, 2016 | -3.262M |
| March 31, 2016 | -0.4255M |
| December 31, 2015 | -0.8709M |
| September 30, 2015 | 0.0034M |
| June 30, 2015 | 0.0035M |
| March 31, 2015 | 0.0012M |
| December 31, 2014 | 0.0012M |
| September 30, 2014 | 0.0012M |
| June 30, 2014 | -0.0001M |
| March 31, 2014 | -0.0002M |
| December 31, 2013 | -0.0014M |
| September 30, 2013 | -0.0378M |
| June 30, 2013 | -0.1319M |
| March 31, 2013 | -0.3704M |
| December 31, 2012 | -0.5848M |
| September 30, 2012 | -0.9151M |
| June 30, 2012 | -1.122M |
| March 31, 2012 | -1.223M |
| December 31, 2011 | -1.806M |
| September 30, 2011 | -1.593M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-11.16M
Minimum
Jun 2022
-1.069M
Maximum
Jun 2019
-5.326M
Average
-4.564M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| NeuBase Therapeutics Inc | -14.78M |
| Sutro Biopharma Inc | -111.62M |
| Reviva Pharmaceuticals Holdings Inc | -28.32M |
| Flora Growth Corp | -8.396M |
| Journey Medical Corp | 5.24M |